These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3469405)

  • 21. Assignment of the human oxidized low-density lipoprotein receptor gene (OLR1) to chromosome 12p13.1-->p12.3, and identification of a polymorphic CA-repeat marker in the OLR1 gene.
    Li X; Bouzyk MM; Wang X
    Cytogenet Cell Genet; 1998; 82(1-2):34-6. PubMed ID: 9763655
    [No Abstract]   [Full Text] [Related]  

  • 22. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL.
    Horton JD; Shimano H; Hamilton RL; Brown MS; Goldstein JL
    J Clin Invest; 1999 Apr; 103(7):1067-76. PubMed ID: 10194480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice.
    Wouters K; Shiri-Sverdlov R; van Gorp PJ; van Bilsen M; Hofker MH
    Clin Chem Lab Med; 2005; 43(5):470-9. PubMed ID: 15899668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene.
    Li J; Fang B; Eisensmith RC; Li XH; Nasonkin I; Lin-Lee YC; Mims MP; Hughes A; Montgomery CD; Roberts JD
    J Clin Invest; 1995 Feb; 95(2):768-73. PubMed ID: 7860759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tale of the Watanabe rabbit.
    Lab Anim (NY); 2012 Oct; 41(10):277. PubMed ID: 22992501
    [No Abstract]   [Full Text] [Related]  

  • 26. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mechanism of hyperlipidemia and future aspects on the therapy].
    Nobuhiro Y
    Nihon Rinsho; 2001 Jan; 59(1):170-4. PubMed ID: 11197850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia.
    Gallagher EJ; Zelenko Z; Neel BA; Antoniou IM; Rajan L; Kase N; LeRoith D
    Oncogene; 2017 Nov; 36(46):6462-6471. PubMed ID: 28759039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic aspects of atherogenic dyslipoproteinemias].
    de Gennes JL
    Ann Biol Clin (Paris); 1986; 44(5):556-8. PubMed ID: 3813140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic research in coronary heart disease.
    Motulsky AG
    Prog Clin Biol Res; 1984; 147():541-8. PubMed ID: 6330756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classifications of the hyperlipidemias.
    Havel RJ
    Annu Rev Med; 1977; 28():195-209. PubMed ID: 193431
    [No Abstract]   [Full Text] [Related]  

  • 32. Human apolipoprotein molecular biology and genetic variation.
    Breslow JL
    Annu Rev Biochem; 1985; 54():699-727. PubMed ID: 3896129
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of chromosome 2 obesity loci on cardiovascular complications of insulin resistance in LDL receptor-deficient C57BL/6 mice.
    Estrada-Smith D; Collins AR; Wang X; Crockett C; Castellani L; Lusis AJ; Davis RC
    Diabetes; 2006 Aug; 55(8):2265-71. PubMed ID: 16873689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Air pollution and antibodies against modified lipoproteins are associated with atherosclerosis and vascular remodeling in hyperlipemic mice.
    Soares SR; Carvalho-Oliveira R; Ramos-Sanchez E; Catanozi S; da Silva LF; Mauad T; Gidlund M; Goto H; Garcia ML
    Atherosclerosis; 2009 Dec; 207(2):368-73. PubMed ID: 19486979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility.
    Hegele RA; Breslow JL
    Genet Epidemiol; 1987; 4(3):163-84. PubMed ID: 2886398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCR methodology applied to genetic studies of lipoprotein metabolism and atherosclerosis.
    Cole SA; Hixson JE
    Methods Mol Biol; 1998; 110():1-34. PubMed ID: 9918036
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change.
    Xu CF; Boerwinkle E; Tikkanen MJ; Huttunen JK; Humphries SE; Talmud PJ
    Genet Epidemiol; 1990; 7(4):261-75. PubMed ID: 1977654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status.
    Malavazi I; Abrão EP; Mikawa AY; Landgraf VO; da Costa PI
    Clin Chem Lab Med; 2004 May; 42(5):525-32. PubMed ID: 15202789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A DNA polymorphism adjacent to the human apolipoprotein CII gene.
    Humphries SE; Jowett NI; Williams L; Rees A; Vella M; Kessling A; Myklebost O; Lydon A; Seed M; Galton DJ
    Mol Biol Med; 1983 Dec; 1(5):463-71. PubMed ID: 6094958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular diagnosis of dyslipoproteinemia].
    Gotoda T; Yazaki Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):760-6. PubMed ID: 12436613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.